Respiratory conditions - quality prescribing strategy: improvement guide 2024 to 2027
Respiratory conditions are a major contributor to ill health, disability, and premature death – the most common conditions being asthma and COPD. This quality prescribing guide is designed to ensure people with respiratory conditions are at the centre of their treatment.
Acknowledgements
ChairpersonsDavid Anderson - Respiratory Consultant, NHS Greater Glasgow and Clyde
Tom Fardon - Respiratory Consultant, NHS Tayside
Deputy Chairperson
Alpana Mair - Head of Effective Prescribing and Therapeutics Division, Scottish Government
Working Group Members
Allan White - Respiratory Advisor, Chest Heart and Stroke Scotland
Alpana Mair - Head of Effective Prescribing and Therapeutics Division, Scottish Government
Andrew Jack - Patient expert with lived experience
Ann Wales - Programme Lead, Knowledge and Decision Support, Digital Health and Care Innovation Centre
Beth Crozier - Senior Policy Officer, Effective Prescribing and Therapeutics Division, Scottish Government
Bryony Murray - Senior Policy Officer, Respiratory and Diabetes, Scottish Government
Caitlin Frickleton - Policy Manager, Diabetes and Respiratory, Scottish Government
Catriona Wheelan - Pharmacist - Secondary Care, NHS Highland
David Anderson - Respiratory Consultant, NHS Greater Glasgow and Clyde
Elizabeth Daniel - Prescribing Respiratory Physiotherapist, NHS Lothian
Emily Kennedy - Clinical Pharmacist, Respiratory and Sustainability Lead, Effective Prescribing and Therapeutics Division, Scottish Government
Euan Reid - Lead Pharmacist - Primary Care, NHS Forth Valley and Scottish Practice Pharmacy & Prescribing Advisers representative
Jacqueline Davidson - Respiratory Specialist Nurse, Secondary Care, NHS Lanarkshire
Joseph Carter - Head of Devolved Nations, Asthma and Lung UK
Julie Lennon - GP Practice Nurse (ANP), NHS Highland and NES Nurse Adviser
Iain Wilson - GP Clinical Lead, Effective Prescribing and Therapeutics Division, Scottish Government
Karen Vint - Clinical Pharmacist, Respiratory and Sustainability, Effective Prescribing and Therapeutics Division, Scottish Government
Katie Johnston - Lead Respiratory Pharmacist, Primary Care, NHS Lothian
Katrina McCormick - Professional Engagement, Chest Heart and Stroke Scotland
Kris McLaughlin - GP, NHS Grampian
Laura Groom - Prescribing Respiratory Physiotherapist, NHS Lothian
Laura Wilson - Policy and Practice Lead, Royal Pharmaceutical Society
Lesley Rose - Clinical Pharmacist, Respiratory Lead, Effective Prescribing and Therapeutics Division, Scottish Government
Linda Mcleod - Patient expert with lived experience
Luke Daines - GP, NHS Lothian and Senior Research / Clinical Teaching Fellow, University of Edinburgh
Lynda Bryceland - Respiratory Specialist Nurse, NHS Ayrshire and Arran
Nadia Hyder Skinner - Senior Policy Officer, Effective Prescribing and Therapeutics Division, Scottish Government
Paul Paxton - Senior Information Analyst, Public Health Scotland
Richard Ousten - Patient expert with lived experience
Stuart Law - Head of Policy and Research, Effective Prescribing and Therapeutics Division, Scottish Government
Stuart McTaggart - Principal Pharmacist, Public Health Scotland
Susannah Lindey - Patient expert with lived experience
Tom Fardon - Respiratory Consultant, NHS Tayside
With acknowledgements to:
Graeme Bryson - Director of Pharmacy, NHS Dumfries and Galloway
Janey Lennon - Prescribing Support Pharmacist, NHS Greater Glasgow and Clyde
Joanna Hutchison - Lead Respiratory Pharmacist, NHS Lothian
Ann McMurray - Asthma Nurse Specialist, Royal Hospital for Children and Young People, NHS Lothian
Contact
Email: EPandT@gov.scot
There is a problem
Thanks for your feedback